Contents
Download PDF
pdf Download XML
157765 Views
11082 Downloads
Share this article
Case Report | Volume 24 Issue 1 (, 2018) | Pages 89 - 91
Trans-Septal Approach for Hypertrophic Obstructive Cardiomyopathy
 ,
 ,
 ,
 ,
Under a Creative Commons license
PMID : -26182625
Published
Jan. 12, 2015
Abstract

Transaortic septal myectomy, known as Morrow's procedure, is a standard treatment for hypertrophic obstructive cardiomyopathy (HOCM). The case is described of a 58-year-old male patient who suffered a repetition of syncope due to HOCM, in whom septal myectomy was performed. As resection of the hypertrophied septum using Morrow's procedure was considered insufficient by palpation to release mitral regurgitation (MR) and systolic anterior motion of the mitral valve, the surgical approach was changed such that the right ventricular outflow tract and ventricular septum was incised. The residual hypertrophied septum was successfully resected to the base of the anterior papillary muscle under direct vision. Postoperative echocardiography demonstrated a dramatic improvement in the MR and left ventricular outflow tract obstruction. The patient's postoperative course was good, with cibenzoline and calcium channel blocker therapy stopped and beta-blocker therapy reduced after surgery. If resection of the hypertrophied septum using Morrow's procedure is considered insufficient, a trans-septal approach represents an adequate option to treat HOCM.

 

 

 

How to cite: Konishi Y, Shomura Y, Fukunaga N, Koyama T, Okada Y. Trans-Septal Approach for Hypertrophic Obstructive Cardiomyopathy. J Heart Valve Dis. 2015 Jan;24(1):89-91. PMID: 26182625.

 
Keywords
Recommended Articles
Research Article
Biological Hip Preservation in Avascular Necrosis of the Femoral Head Using Autologous Cultured Osteoblasts in ARCO Grade I and II: A 6-Year Follow-Up Study of 15 Cases
Published: 21/03/2013
Download PDF
Read Article
Research Article
Published: 27/06/2025
Download PDF
Read Article
Research Article
Published: 21/03/2013
Download PDF
Read Article
Research Article
High-Concentration Platelet-Rich Plasma Using the ACP Max System as a Fibrin Scaffold Combined With Viscosupplementation for Knee Osteoarthritis (Kellgren–Lawrence Grade 2 and 3): A 3-Year Prospective Clinical Study
Published: 07/04/2013
Download PDF
Read Article
© Copyright Journal of Heart Valve Disease